Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Paediatric Respiratory Reviews
|
November 26, 2008
Ventilatory strategies in the neonatal and paediatric intensive care units
Giulia Mesiano, G Michael Davis
Oncoimmunology
|
July 23, 2014
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Current Gene Therapy
|
December 25, 2013
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors
Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|
July 14, 2017
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients
Claudia Casnici, Katia Crotta, Gisella Volpe, et al.
Expert Opinion on Biological Therapy
|
May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective
Loretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Discover Nano
|
February 14, 2024
Anti-CD38 targeted nanotrojan horses stimulated by acoustic waves as therapeutic nanotools selectively against Burkitt's lymphoma cells
Veronica Vighetto, Marzia Conte, Giada Rosso, et al.
International Journal of Molecular Sciences
|
December 23, 2022
Artificial and Naturally Derived Phospholipidic Bilayers as Smart Coatings of Solid-State Nanoparticles: Current Works and Perspectives in Cancer Therapy
Nicolò Maria Percivalle, Marco Carofiglio, Marzia Conte, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy
Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 16, 2020
Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation
Katia Mareschi, Aloe Adamini, Sara Castiglia, et al.
Journal of Translational Medicine
|
October 12, 2018
Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
Sara Castiglia, Aloe Adamini, Deborah Rustichelli, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Paediatric Respiratory Reviews
|
November 26, 2008
Ventilatory strategies in the neonatal and paediatric intensive care units
Giulia Mesiano, G Michael Davis
Oncoimmunology
|
July 23, 2014
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Current Gene Therapy
|
December 25, 2013
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors
Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|
July 14, 2017
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients
Claudia Casnici, Katia Crotta, Gisella Volpe, et al.
Expert Opinion on Biological Therapy
|
May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective
Loretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Discover Nano
|
February 14, 2024
Anti-CD38 targeted nanotrojan horses stimulated by acoustic waves as therapeutic nanotools selectively against Burkitt's lymphoma cells
Veronica Vighetto, Marzia Conte, Giada Rosso, et al.
International Journal of Molecular Sciences
|
December 23, 2022
Artificial and Naturally Derived Phospholipidic Bilayers as Smart Coatings of Solid-State Nanoparticles: Current Works and Perspectives in Cancer Therapy
Nicolò Maria Percivalle, Marco Carofiglio, Marzia Conte, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy
Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 16, 2020
Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation
Katia Mareschi, Aloe Adamini, Sara Castiglia, et al.
Journal of Translational Medicine
|
October 12, 2018
Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
Sara Castiglia, Aloe Adamini, Deborah Rustichelli, et al.
Page
of 3